Abpro Holdings Inc
ABPWW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.38K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $12,382.00 |
|---|---|
| Enterprise Value | $-4,052,618.00 |
| Earnings per Share | $-1.3 |
| Beta | 0.14 |
| Outstanding Shares | 5,896,048 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | 38.37% |
| Return on Invested Capital | 178.99% |
Valuation & Multiples
| P/E Ratio | 0.19 |
|---|---|
| PEG | -0.27 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.93 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-1.20
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Atlantic Coastal Acquisition Corp II
2,021 employees
CEO: Fatih Karatas
Abpro Holdings, Inc. is a biotechnology firm specializing in the creation of innovative antibody treatments, primarily targeting immuno-oncology and ophthalmology. The company leverages two proprietary technological platforms: DiversImmu...